75886-2
LOINC Code
| LOINC code | 75886-2 | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| name | |||||||||||||||||||||||||||||||||||||||||||||||
| description | Panel for qualitative or quantitative screening for Hepatitis C virus antibodies using any laboratory method except immunoblot assay (IB). This panel was created for Meaningful Use 3 as part of a project by the American Medical Association (AMA) to develop three Clinical Quality Measures for Hepatitis C - 1) One-Time Screening for HCV for Patients at Risk, 2) HCV Screening for Active Injection Drug Users, and 3) Appropriate Screening Follow-up for Patients with HCV Infection. This concept may be used by a physician to document that he/she has reviewed the HCV antibody test results performed by an outside lab. When the physician does not know which specific LOINC code to choose when documenting the test and results from the lab report, this more generic LOINC panel code can be used. The HCV antibody screening panel includes all antibody tests using any method such as EIA but excluding immunoblotting assay (IB) method, since IB is confirmatory Ab test for HCV. In the eMeasure, this LOINC panel and associated LOINCs codes will be included in a larger value set for the specific type of screening - HCV Antibody Test. | ||||||||||||||||||||||||||||||||||||||||||||||
| status | ACTIVE | ||||||||||||||||||||||||||||||||||||||||||||||
Fully-Specified Name | |||||||||||||||||||||||||||||||||||||||||||||||
| component | HCV antibody screening tests - Meaningful Use set | ||||||||||||||||||||||||||||||||||||||||||||||
| property | - | ||||||||||||||||||||||||||||||||||||||||||||||
| time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||||||||||||||||||||||||||||||||||||||||||||||
| system | ^Patient | ||||||||||||||||||||||||||||||||||||||||||||||
| scale | - | ||||||||||||||||||||||||||||||||||||||||||||||
| method | |||||||||||||||||||||||||||||||||||||||||||||||
Additional Names | |||||||||||||||||||||||||||||||||||||||||||||||
| short name | Ab; Asympt; Asymptomatic; HCV Ab MU Set; Hepatology; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; Panel; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Scn | ||||||||||||||||||||||||||||||||||||||||||||||
Basic Attributes | |||||||||||||||||||||||||||||||||||||||||||||||
| class | PANEL.MICRO | ||||||||||||||||||||||||||||||||||||||||||||||
| type | 1 Laboratory | ||||||||||||||||||||||||||||||||||||||||||||||
| order vs. observation | HCV Ab MU Set P | ||||||||||||||||||||||||||||||||||||||||||||||
Panel Components | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
History/Usage | |||||||||||||||||||||||||||||||||||||||||||||||
| first released | |||||||||||||||||||||||||||||||||||||||||||||||
| last updated | 2.58 | ||||||||||||||||||||||||||||||||||||||||||||||
| last change type | MIN - change to field other than name | ||||||||||||||||||||||||||||||||||||||||||||||
Related Names | |||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2026 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2026, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com